V Schreiber

526 total citations
58 papers, 398 citations indexed

About

V Schreiber is a scholar working on Endocrinology, Diabetes and Metabolism, Physiology and Molecular Biology. According to data from OpenAlex, V Schreiber has authored 58 papers receiving a total of 398 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Endocrinology, Diabetes and Metabolism, 11 papers in Physiology and 9 papers in Molecular Biology. Recurrent topics in V Schreiber's work include Growth Hormone and Insulin-like Growth Factors (11 papers), Thyroid Disorders and Treatments (8 papers) and Hormonal Regulation and Hypertension (6 papers). V Schreiber is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (11 papers), Thyroid Disorders and Treatments (8 papers) and Hormonal Regulation and Hypertension (6 papers). V Schreiber collaborates with scholars based in Czechia, United States and Germany. V Schreiber's co-authors include J Nedvı́dková, Martin Haluzı́k, J Štěpán, James O. Farlow, Edwin H. Colbert, T Pribýl, Z Jarkovská, J Marek, Michal Kršek and M Rosická and has published in prestigious journals such as Nature, Brain Research and Endocrinology.

In The Last Decade

V Schreiber

55 papers receiving 370 citations

Peers

V Schreiber
Marianne T. Neary United Kingdom
Jan Amstrup Denmark
Richard C. Dimond United States
K. D. Fagin United States
Tai‐Chan Peng United States
J. Schwartz Australia
A. Penhoat France
Robert E. Greenberg United States
Vera Teixeira Portugal
Marianne T. Neary United Kingdom
V Schreiber
Citations per year, relative to V Schreiber V Schreiber (= 1×) peers Marianne T. Neary

Countries citing papers authored by V Schreiber

Since Specialization
Citations

This map shows the geographic impact of V Schreiber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V Schreiber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V Schreiber more than expected).

Fields of papers citing papers by V Schreiber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V Schreiber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V Schreiber. The network helps show where V Schreiber may publish in the future.

Co-authorship network of co-authors of V Schreiber

This figure shows the co-authorship network connecting the top 25 collaborators of V Schreiber. A scholar is included among the top collaborators of V Schreiber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V Schreiber. V Schreiber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lourie, Rohan, Hui Tong, V Schreiber, et al.. (2016). High fat diets induce colonic epithelial cell stress and inflammation that is reversed by IL-22. Queensland's institutional digital repository (The University of Queensland). 1 indexed citations
2.
Horký, K, V Schreiber, & Jana Dvořáková. (2009). The Effect of Long-Term Treatment with Spironolactone on Sodium Pump Abnormalities in the Red Blood Cells of Patients with Bartter's Syndrome. Experimental and Clinical Endocrinology & Diabetes. 84(4). 105–111. 1 indexed citations
3.
Rosická, M, Michal Kršek, Z Jarkovská, J Marek, & V Schreiber. (2002). Ghrelin - a new endogenous growth hormone secretagogue. Physiological Research. 51(5). 435–441. 31 indexed citations
4.
Nedvı́dková, J, Hana Papežová, Martin Haluzı́k, & V Schreiber. (2000). Interaction Between Serum Leptin Levels and Hypothalamo-Hypophyseal-Thyroid Axis in Patients with Anorexia Nervosa. Endocrine Research. 26(2). 219–230. 21 indexed citations
5.
Brtko, Július, J Nedvı́dková, Martin Haluzı́k, & V Schreiber. (1997). Comparison ofin vivolong - term treatment of rats by methylene blue with itsin vitroeffects on thyroid hormone - nuclear receptor complex formation in liver. Endocrine Research. 23(3). 157–165. 1 indexed citations
6.
Nedvı́dková, J, V Schreiber, & L Stárka. (1997). In vivo antiestrogenic activity of mifepristone in the rat. Journal of Endocrinological Investigation. 20(4). 225–229. 4 indexed citations
7.
Schreiber, V, et al.. (1997). Possible participation of EDRF-NO in the hormonal regulation of bone blood flow in rats.. PubMed. 46(1). 15–20. 2 indexed citations
8.
Nedvı́dková, J, et al.. (1996). Triiodothyronine attenuates estradiol-induced increases in dopamine D-2 receptor number in rat anterior pituitary. Brain Research. 712(1). 148–152. 10 indexed citations
9.
Nedvı́dková, J, I Šterzl, Martin Haluzı́k, & V Schreiber. (1995). An increase in the blood thyroxine level after methylene blue in rats: The interaction with carbimazole. Endocrine Research. 21(4). 709–717. 4 indexed citations
10.
Kraml, J, et al.. (1995). Early and delayed effects of hydrocortisone and onapristone on intestinal brush-border enzymes and their sialylation and on thymus growth in suckling rats. The Journal of Steroid Biochemistry and Molecular Biology. 52(3). 251–257. 7 indexed citations
11.
Haluzı́k, Martin, J Nedvı́dková, & V Schreiber. (1995). Methylene blue--an endocrine modulator.. PubMed. 96(4). 319–22. 2 indexed citations
12.
Nedvı́dková, J, et al.. (1994). An Analog of MIF, Alaptide: Effect on Serum Prolactin, Dopamine Receptors and Growth of Rat Adenohypophysis. Endocrine Research. 20(1). 39–46. 4 indexed citations
13.
Nedvı́dková, J & V Schreiber. (1992). The increase in cAMP and cGMP levels in the oestrogenized rat hypophysis.. PubMed. 41(4). 279–84. 4 indexed citations
14.
Štěpán, J, J Pospíchal, V Schreiber, et al.. (1989). The application of plasma tartrate-resistant acid phosphatase to assess changes in bone resorption in response to artificial menopause and its treatment with estrogen or norethisterone. Calcified Tissue International. 45(5). 273–280. 34 indexed citations
15.
Slíva, Daniel, et al.. (1985). The binding of 3H digoxin by rat myocardial membranes in experimental cardiac hypertrophy. Journal of Molecular and Cellular Cardiology. 17. 19–19. 2 indexed citations
16.
Schreiber, V, et al.. (1968). Effect of codeine on thyroid function in the rat.. PubMed. 17(3). 253–8. 2 indexed citations
17.
Schreiber, V. (1967). Thyrotrophin-Releasing Factor: Purification, Mechanism and Blockage of Action (a Review). Neuroendocrinology. 2(3). 175–191. 2 indexed citations
18.
Schreiber, V, et al.. (1965). Thyroxine in the Early Postnatal Period: Minimal Changes in Thyroid Function. Neuroendocrinology. 1(2). 121–128. 4 indexed citations
19.
Schreiber, V, et al.. (1964). Inhibition ofin vitro release of thyreotrophin by an analogue of oxytocin, 3-valine-oxytocin. Cellular and Molecular Life Sciences. 20(12). 673–674.
20.
Schreiber, V, et al.. (1962). Isolation of a hypothalamic peptide with TRF (thyreotrophin releasing factor) activityin vitro. Cellular and Molecular Life Sciences. 18(7). 338–340. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026